Landscapes / Targets
LAT1
4 drugs act on LAT1, in 5 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Oct 2027Phase 3 trial completes | |||
| Next date | Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC) | ||||
| Open drug page | |||||
— |
Phase 3 | Jul 2028Phase 3 trial completes | |||
| Next date | Jul 2028 · Phase 3 trial completes | ||||
| Also tested for | Neoplastic Disease, Glioblastoma and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 28 Feb 2028Phase 1/2 trial completes | |||
| Next date | 28 Feb 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026